Literature DB >> 27358114

Worldwide burden of gastric cancer in 2010 attributable to high sodium intake in 1990 and predicted attributable burden for 2030 based on exposures in 2010.

Bárbara Peleteiro1, Susana Barros1, Clara Castro1, Ana Ferro1, Samantha Morais1, Nuno Lunet1.   

Abstract

Assessing the impact that patterns of Na intake may have on gastric cancer will provide a more comprehensive estimation of Na reduction as a primary prevention approach. We aimed to estimate the proportion of gastric cancer cases that are attributable to Na intake above the recommendation by the WHO (≤2 g/d) throughout the world in 2010, as well as expected values for 2030. Population attributable fractions (PAF) were computed for 187 countries, using Na intakes in 1990 and 2010 and estimates of the association between Na intake and gastric cancer, assuming a time lag of 20 years. Median PAF ranged from 10·1% in low to 22·5 % in very high Human Development Index (HDI) countries in men (P<0·001) and from 7·2 to 16·6 %, respectively, among women (P<0·001). An increase in median PAF until 2030 is expected in most settings, except for countries classified as low HDI, in both sexes. High Na intakes account for a large proportion of gastric cancer cases, and proportions are expected to increase in almost all of the countries. Intensified efforts to diminish Na intake in virtually all populations are needed to further reduce gastric cancer burden.

Entities:  

Keywords:  HDI Human Development Index; PAF population attributable fraction; Population attributable fractions; Predictions; RR relative risk; Sodium; Stomach neoplasms

Mesh:

Substances:

Year:  2016        PMID: 27358114     DOI: 10.1017/S0007114516002518

Source DB:  PubMed          Journal:  Br J Nutr        ISSN: 0007-1145            Impact factor:   3.718


  7 in total

1.  Association between Body Mass Index and Risk of Gastric Cancer by Anatomic and Histologic Subtypes in Over 500,000 East and Southeast Asian Cohort Participants.

Authors:  Jieun Jang; Sangjun Lee; Kwang-Pil Ko; Sarah K Abe; Md Shafiur Rahman; Eiko Saito; Md Rashedul Islam; Norie Sawada; Xiao-Ou Shu; Woon-Puay Koh; Atsuko Sadakane; Ichiro Tsuji; Jeongseon Kim; Isao Oze; Chisato Nagata; Shoichiro Tsugane; Hui Cai; Jian-Min Yuan; Yu-Tang Gao; Kotaro Ozasa; Sanae Matsuyama; Seiki Kanemura; Aesun Shin; Hidemi Ito; Keiko Wada; Yumi Sugawara; Yu Chen; Habibul Ahsan; Paolo Boffetta; Kee Seng Chia; Keitaro Matsuo; You-Lin Qiao; Nathaniel Rothman; Wei Zheng; Manami Inoue; Daehee Kang; Sue K Park
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2022-09-02       Impact factor: 4.090

2.  High sodium intake increases blood pressure and risk of kidney disease. From the Science of Salt: A regularly updated systematic review of salt and health outcomes (August 2016 to March 2017).

Authors:  Daniela Malta; Kristina S Petersen; Claire Johnson; Kathy Trieu; Sarah Rae; Katherine Jefferson; Joseph Alvin Santos; Michelle M Y Wong; Thout Sudhir Raj; Jacqui Webster; Norm R C Campbell; JoAnne Arcand
Journal:  J Clin Hypertens (Greenwich)       Date:  2018-11-07       Impact factor: 3.738

3.  Salt content of instant noodles in Malaysia: a cross-sectional study.

Authors:  Chun Han Tan; Zhen Yee Chow; Siew Mooi Ching; Navin Kumar Devaraj; Feng J He; Graham A MacGregor; Yook Chin Chia
Journal:  BMJ Open       Date:  2019-05-01       Impact factor: 2.692

4.  Association between dietary sodium, potassium intake and lung cancer risk: evidence from the prostate, lung, colorectal and ovarian cancer screening trial and the Women's Health Initiative.

Authors:  Dongfang You; Mingzhi Zhang; Wenjing He; Danhua Wang; Yang Yu; Zhaolei Yu; Theis Lange; Sheng Yang; Yongyue Wei; Hongxia Ma; Zhibin Hu; Hongbing Shen; Feng Chen; Yang Zhao
Journal:  Transl Lung Cancer Res       Date:  2021-01

5.  RNF43 and PWWP2B inhibit cancer cell proliferation and are predictive or prognostic biomarker for FDA-approved drugs in patients with advanced gastric cancer.

Authors:  Sung-Hwa Sohn; Hee Jung Sul; Bohyun Kim; Hyeong Su Kim; Bum Jun Kim; Hyun Lim; Ho Suk Kang; Jae Seung Soh; Kab Choong Kim; Ji Woong Cho; Jinwon Seo; Youngho Koh; Dae Young Zang
Journal:  J Cancer       Date:  2021-06-01       Impact factor: 4.207

6.  Foretinib Inhibits Cancer Stemness and Gastric Cancer Cell Proliferation by Decreasing CD44 and c-MET Signaling.

Authors:  Sung-Hwa Sohn; Bohyun Kim; Hee Jung Sul; Bo Youn Choi; Hyeong Su Kim; Dae Young Zang
Journal:  Onco Targets Ther       Date:  2020-02-03       Impact factor: 4.147

7.  Interaction between fasting blood glucose and tumor embolus in predicting the postoperative prognosis of 4330 Chinese patients with gastrointestinal tract cancer.

Authors:  Dan Hu; Xinran Zhang; Xiandong Lin; Hejun Zhang; Yan Xia; Jinxiu Lin; Xiongwei Zheng; Feng Peng; Wenquan Niu
Journal:  J Cancer       Date:  2020-01-01       Impact factor: 4.207

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.